Why I'm Buying Oscar's Panic Dip

Yiannis Zourmpanos
10.43K Followers

Summary

  • Centene’s $1.8B ACA risk shock triggered a ~15-20% drop in Oscar’s stock but didn’t alter Q1 fundamentals.
  • Oscar posted 42% revenue growth, expanding to 2 million members with a record-low 15.8% SG&A expense ratio.
  • Barclays’ downgrade highlights policy risk, projecting over 100bps MLR pressure and aggressive EPS cuts if subsidies expire.
  • Oscar’s full-stack tech, Campaign Builder AI, and high NPS retention power a unique flywheel that legacy insurers lack.
  • Even with expected H2 membership declines, Oscar’s $4.9B cash buffer and undervalued 0.46x P/S multiple show upside.

Artificial Intelligence in Healthcare - New AI Applications in Medicine

ArtemisDiana

Investment Thesis

The Centene (CNC) shock has rattled the ACA sector, dragging Oscar Health (NYSE:OSCR) down by ~15-20% on fears of higher-than-expected claims risk. But this selloff looks like pure overreaction. Oscar just posted record Q1 results, 42% revenue growth, expanding membership

This article was written by

10.43K Followers
Hi, I'm Yiannis. Spotting winners before they break out is what I do best.Experience: Previously worked at Deloitte and KPMG in external/internal auditing and consulting. Education: Chartered Certified Accountant, Fellow Member of ACCA Global, with BSc and MSc degrees from U.K. business schools. Investment Style: Spotting high-potential winners before they break out, focusing on asymmetric opportunities (with at least upside potential of 2-3X outweighing the downside risk). By leveraging market inefficiencies and contrarian insights, we seek to maximize long-term compounding while protecting against capital impairment.Risk management is paramount—we seek a strong margin of safety to protect against capital impairment while maximizing long-term compounding. Our 4-5 year investment horizon allows us to ride out volatility, ensuring that patience, discipline, and intelligent capital allocation drive outsized returns over time.Investment Methodology: Identifying High-Conviction Opportunities1️⃣ Leadership & Management Analysis • Proven track record in scaling businesses. • Smart capital allocation and insider ownership. • Consistent revenue growth and credible guidance. 2️⃣ Market Disruption & Competitive Positioning • Strong technology moat and first-mover advantage. • Network effects that drive exponential growth. • Market penetration in high-growth industries. 3️⃣ Financial Health & Risk Management • Sustainable revenue growth with efficient cash flow. • Strong balance sheet and long-term survival runway. • Avoiding excessive dilution and financial weakness. 4️⃣ Valuation & Asymmetric Risk/Reward • Revenue multiples vs. peers and DCF modeling. • Institutional backing and market sentiment analysis. • Ensuring downside protection with massive upside. 5️⃣ Portfolio Construction & Risk Control • Core Positions (50-70%) – High-confidence, stable plays. • Growth Bets (20-40%) – High-risk, high-reward opportunities. • Speculative (5-10%) – Moonshot disruptors with massive potential.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of OSCR either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About OSCR Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on OSCR

Related Stocks

SymbolLast Price% Chg
OSCR
--